(Q38428770)

English

Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents

scientific article published on 04 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

methicillin-resistant Staphylococcus aureus

0 references

1 reference

based on heuristic

1 reference

based on heuristic

sulfamethoxazole/trimethoprim

1 reference

based on heuristic

Staphylococcus aureus

1 reference

based on heuristic

16

object named as

Keith S Kaye

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Michael J Rybak

15

object named as

Michael J Rybak

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

13

object named as

Emily T Martin

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

author name string

Michelle L Campbell

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Dror Marchaim

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Jason M Pogue

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Bharath Sunkara

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Suchitha Bheemreddy

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Pradeep Bathina

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Harish Pulluru

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Neelu Chugh

8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Melanie N Wilson

9

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Judy Moshos

10

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Kimberley Ku

11

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Kayoko Hayakawa

12

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Paul R Lephart

14

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

0 references

publication date

4 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Annals of Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1587-1597

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA).

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Characterization of global patterns and the genetics of fusidic acid resistance

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Dissemination of an Enterococcus Inc18-Like vanA plasmid associated with vancomycin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient--a review of the literature

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Does trimethoprim-sulfamethoxazole prophylaxis for HIV induce bacterial resistance to other antibiotic classes? Results of a systematic review

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: a population-based study

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1R211

21 January 2018

Identifiers

10.1345/APH.1R211

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38428770&oldid=1783904730"